GMARK 50
Precision-Release Neuropathic Support
Overview
GMARK 50 is a specialized Sustained-Release (SR) formulation of Pregabalin, a potent gabapentinoid designed to provide consistent, 24-hour relief from neuropathic pain. By utilizing advanced drug-delivery technology, GMARK 50 ensures a steady therapeutic plasma concentration, reducing the frequency of dosing and minimizing the side effects often associated with immediate-release medications.
Key Composition
Each film-coated sustained-release tablet contains:
- Pregabalin (50 mg): A high-affinity ligand for the $α_2δ$ (alpha-2-delta) subunit of voltage-gated calcium channels in the central nervous system.
Mechanism of Action
GMARK 50 works by modulating the electrical activity of overexcited neurons:
- Calcium Channel Modulation: It binds to the calcium channels in the CNS, reducing the influx of calcium into nerve terminals.
- Neurotransmitter Regulation: This action decreases the release of several excitatory neurotransmitters, including glutamate, norepinephrine, and substance P, thereby "calming" the damaged or hyper-responsive nerves.
- Sustained Delivery: The SR matrix allows for a gradual release of the active ingredient, providing a stable therapeutic window that helps maintain long-term neuronal stability.
The GMARK 50 Advantage
- Consistent Relief: The sustained-release profile prevents the "peak-and-valley" effect, ensuring the patient remains within the therapeutic range throughout the day and night.
- Improved Compliance: Ideally suited for patients starting therapy or those requiring precise, low-dose titration.
- Lower Side-Effect Profile: Reduced peak plasma levels lead to a lower incidence of dizziness and somnolence compared to conventional immediate-release pregabalin.
- Enhanced Sleep Quality: By providing steady pain relief through the night, GMARK 50 helps restore normal sleep patterns in patients with chronic pain.
Dosage & Administration
As prescribed by a physician. GMARK 50 is typically taken once daily, preferably after an evening meal. Tablets should be swallowed whole and must not be crushed or chewed to preserve the sustained-release mechanism.